Cytotoxic effect of paclitaxel incorporated in nanoparticles based on lactic and glycolic acid copolymer

Bull Exp Biol Med. 2011 Jul;151(3):340-3. doi: 10.1007/s10517-011-1325-9.
[Article in English, Russian]

Abstract

Paclitaxel dosage form on nanoparticles of 200-300 nm based on lactic and glycolic acid copolymer was obtained by the co-precipitation method. The possibility of controlled release of paclitaxel at pH 7.4 for 24 h was studied in vitro. Studies on Jurkat/WT human T-lymphoblastic leukemia cells showed that incorporation of paclitaxel in the nanoparticles led to a 4-fold increase of its cytotoxicity (6.8×10(-6) M) in comparison with paclitaxel solution. The efficiency of compositions containing polysorbate-80 was comparable to that of non-modified nanoparticles containing paclitaxel.

MeSH terms

  • Antineoplastic Agents, Phytogenic / adverse effects
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / toxicity
  • Cell Line, Tumor
  • Delayed-Action Preparations / chemistry*
  • Delayed-Action Preparations / pharmacology*
  • Drinking Behavior / drug effects
  • Drug Delivery Systems / methods*
  • Glycolates / chemistry
  • Humans
  • Jurkat Cells
  • Lactic Acid / chemistry
  • Nanoparticles / chemistry*
  • Paclitaxel / adverse effects
  • Paclitaxel / pharmacology*
  • Paclitaxel / toxicity
  • Polymers / chemistry
  • Polymers / pharmacology
  • Polysorbates / chemistry
  • Polysorbates / pharmacology

Substances

  • Antineoplastic Agents, Phytogenic
  • Delayed-Action Preparations
  • Glycolates
  • Polymers
  • Polysorbates
  • glycolic acid
  • Lactic Acid
  • Paclitaxel